Minimum fixation angle prevents postoperative pIOL rotation

Article

Toric phakic intraocular lens (pIOL) intraoperative fixation angle should be kept to a minimum to avoid postoperative rotation.

Toric phakic intraocular lens (pIOL) intraoperative fixation angle should be kept to a minimum to avoid postoperative rotation, claims a study in the Journal of Cataract and Refractive Surgery.

Dr Takashi Kjima et al., Nagoya Eye Clinic, Nagoya, Japan, conducted a case series on 34 patients implanted with a toric implantable collamer pIOL. The pIOL axis was recorded by calculating ocular internal cylinder power and the axis using the total refractive cylinder and corneal astigmatism using vector analysis.

Preoperative manifest refractive sphere, preoperative manifest spherical equivalent, mean keratometric power, axial length, toric pIOL intraoperative fixation angle, postoperative toric pIOL vault and toric spherical power were among the potential factors that were associated with toric pIOL rotation. They were all correlated with toric pIOL rotation over six months postoperatively.

Postoperative toric pIOL rotation and intraoperative toric pIOL fixation angle were strongly correlated. Mean rotation six months postoperatively was 4.82 ± 6.98 degrees. The toric pIOL was swapped for a larger toric pIOL in one eye with significant pIOL rotation.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.